波罗样酶1通过驱动微管体动力学来调节免疫突触组合和细胞毒性T细胞功能
Fabrizia Zevolini1, Anna Onnis1, Roxana Khazen2
1Department of Life Sciences, University of Siena, Siena 53100, Italy.
Journal of cell science
|December 12, 2023
概括
波罗样酶1 (PLK1) 对于细胞毒性T淋巴细胞 (CTL) 免疫突触组合和功能至关重要. 抑制PLK1会损害CTLs向和杀死受感染或瘤细胞的能力.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 细胞毒性T淋巴细胞 (CTLs) 通过免疫突触 (IS) 消除受感染或瘤细胞.
- CTLs将它们的中心体和细胞骨两极分向IS,以便有针对性的溶解颗粒的输送.
- Aurora A 激酶与 CTL 功能有关,这表明其基质 PLK1.1 的作用.
研究的目的:
- 研究波罗样酶1 (PLK1) 在细胞毒性T淋巴细胞 (CTL) 免疫突触 (IS) 组合和功能中的作用.
- 确定PLK1是否参与控制CTL介导细胞毒性的信号通路.
主要方法:
- 在T细胞受体 (TCR) 触发时研究了PLK1酸化.
- 评估了PLK1对IS的偏向.
- 利用PLK1静音和抑制来评估IS组件和功能.
- 分析了TCR积累,中心体和质颗粒的两极分化,以及细胞杀死效率.
主要成果:
- 在TCR触发时,PLK1被酸化并极化到IS.
- 沉默或抑制PLK1会损害IS组合,由有缺陷的TCR,中心体和质颗粒极化证明.
- 损坏的IS组件导致CTLs减少目标细胞的杀死.
- PLK1将早期信号事件与微管动力学结合在一起,这对于CTL细胞毒性至关重要.
结论:
- PLK1是细胞毒性T淋巴细胞免疫突触组装和功能的新型和关键调节器.
- PLK1在引导细胞毒性机制向目标细胞中发挥着关键作用.
- 向PLK1可能为增强CTL介导的抗病毒和抗瘤免疫提供治疗策略.
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
T Cell Activation and Clonal Selection
741
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
741
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


